In recent years, the medical industry has pursued the application of stem cells in treating many different diseases.
ABC aims to harness the positive effects of regenerative medicine to target vascular disease, the leading cause of global mortality and morbidity.
Vascular diseases include congestive heart failure, coronary artery disease, peripheral artery disease, stroke, chronic kidney disease, erectile dysfunction, and many more. Vascular diseases are major causes of morbidity and mortality in developed countries and are presently incurable.
With stem cell therapy, the goal is to go beyond the current standard of treatment. For certain incurable diseases, such as chronic end-organ threatening ischemia, stem cell therapy aims for improving the functionality and quality of the patient's life, which can also extend one's lifespan. While an effective treatment for vascular disease remains elusive, newer interventions using cell therapy are promising. Regenerative vascular cell therapy has the potential to reverse the progression of vascular disease, offering patients the ability to return to their baseline quality of life.
*Note: For complete description of therapeutics and diagnostics with citations, please refer to ABC ICO Prospectus